Molecular Tumor Board (MTB)
Increased knowledge of cancer molecular biology and research methods development has enabled the spread of gene-guided treatment of cancer. Molecular Tumor Board’s (MTB) mission is to implement and develop personalized cancer care in the VSSHP area.
The MTB is a monthly multidisciplinary meeting attended by cancer physicians, pathologists, geneticists, clinical chemists, and molecular biology experts. The meeting will address cancer patient cases in which a comprehensive genomic profiling test has been performed on a cancer sample or blood. Based on the molecular changes found in gene profiling, the aim is to obtain more information about the nature of the cancer, to find the optimal drug treatment for the cancer, and to provide an assessment of the possible heritability of the genetic change and the need for further studies. In addition, the meeting will address a wide range of current issues related to gene-guided cancer treatment to increase physicians awareness.